Literature DB >> 24743047

Relationship Between Fat-Soluble Vitamin Supplementation and Blood Concentrations in Adolescent and Adult Patients With Cystic Fibrosis.

Oranan Siwamogsatham1, Wei Dong2, Jose N Binongo3, Ritam Chowdhury4, Jessica A Alvarez5, Shawna J Feinman6, Jessica Enders7, Vin Tangpricha8.   

Abstract

Background: Pancreatic insufficiency is common in patients with cystic fibrosis (CF) and leads to malabsorption of fat-soluble vitamins. Multivitamins, including vitamins A, D, E, and K, are routinely prescribed to patients with CF to prevent vitamin deficiencies. Our objective was to examine the relationship between fat-soluble vitamin supplements and their impact on blood concentrations.
Methods: This was a retrospective chart review of patients with CF who were treated at Emory Clinic and Emory University Hospital during 2008-2012. The amount of fat-soluble vitamin supplementation, serum markers of fat-soluble vitamin concentrations, CF transmembrane conductance regulator genotype, and other demographic information were recorded from electronic medical records. Mixed-effects models were used to investigate the trends over time of fat-soluble vitamin supplements and serum vitamin concentrations.
Results: In total, 177 charts were eligible. Mean (SD) age was 26.1 (10.2) years. Ninety-two percent of patients had pancreatic insufficiency and 52% had the homozygous ΔF508 mutation. Recorded fat-soluble vitamin supplementation increased in the past 5 years (P < .001 for all). Serum 25-hydroxyvitamin D increased slightly (3% increase; P < .01); however, there were no changes in the blood concentrations of vitamins A, E, and K (P = .26-.96). Conclusions: Despite a near doubling of recorded fat-soluble vitamin supplementation over the past 5 years, there was no parallel increase in blood concentrations of these vitamins. Potential reasons include suboptimal dosages, low adherence, or ongoing issues with malabsorption.
© 2014 American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  avitaminosis; cystic fibrosis; vitamin A; vitamin D; vitamin E; vitamin K

Year:  2014        PMID: 24743047      PMCID: PMC4201651          DOI: 10.1177/0884533614530170

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  60 in total

Review 1.  The role of vitamins in cystic fibrosis.

Authors:  S B Carr; J McBratney
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

2.  Night blindness in a teenager with cystic fibrosis.

Authors:  Marie Frances Roddy; Peter Greally; Geraldine Clancy; Gerardine Leen; Sinead Feehan; Basil Elnazir
Journal:  Nutr Clin Pract       Date:  2011-09-29       Impact factor: 3.080

3.  Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis.

Authors:  Michael P Boyle; Michelle L Noschese; Sharon L Watts; Marsha E Davis; Shane E Stenner; Noah Lechtzin
Journal:  Am J Respir Crit Care Med       Date:  2005-04-28       Impact factor: 21.405

4.  An unusual cause of hypercalcaemia in a patient with cystic fibrosis.

Authors:  I J Clifton; A M Morton; D G Peckham; S P Conway
Journal:  J Cyst Fibros       Date:  2007-01-30       Impact factor: 5.482

5.  Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis.

Authors:  C S Haworth; P L Selby; A K Webb; E B Mawer; J E Adams; T J Freemont
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

6.  Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen.

Authors:  A P Feranchak; M K Sontag; J S Wagener; K B Hammond; F J Accurso; R J Sokol
Journal:  J Pediatr       Date:  1999-11       Impact factor: 4.406

7.  An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation.

Authors:  V Tangpricha; A Kelly; A Stephenson; K Maguiness; J Enders; K A Robinson; B C Marshall; D Borowitz
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

8.  Vitamin A deficiency and nocturnal vision in teenagers with cystic fibrosis.

Authors:  F Huet; D Semama; C Maingueneau; A Charavel; J L Nivelon
Journal:  Eur J Pediatr       Date:  1997-12       Impact factor: 3.183

9.  Vitamin d deficiency in cystic fibrosis.

Authors:  William B Hall; Amy A Sparks; Robert M Aris
Journal:  Int J Endocrinol       Date:  2010-01-28       Impact factor: 3.257

10.  Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition.

Authors:  Rebecca L Koscik; Philip M Farrell; Michael R Kosorok; Kathleen M Zaremba; Anita Laxova; Hui-Chuan Lai; Jeff A Douglas; Michael J Rock; Mark L Splaingard
Journal:  Pediatrics       Date:  2004-06       Impact factor: 7.124

View more
  10 in total

1.  Changes in Mineral Micronutrient Status During and After Pulmonary Exacerbation in Adults With Cystic Fibrosis.

Authors:  Moon Jeong Lee; Jessica A Alvarez; Ellen M Smith; David W Killilea; James F Chmiel; Patricia M Joseph; Ruth E Grossmann; Amit Gaggar; Thomas R Ziegler; Vin Tangpricha
Journal:  Nutr Clin Pract       Date:  2015-06-15       Impact factor: 3.080

Review 2.  Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.

Authors:  Oranan Siwamogsatham; Jessica A Alvarez; Vin Tangpricha
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

3.  Exogenous and endogenous determinants of vitamin K status in cystic fibrosis.

Authors:  Patrycja Krzyżanowska; Andrzej Pogorzelski; Wojciech Skorupa; Jerzy Moczko; Philip Grebowiec; Jarosław Walkowiak
Journal:  Sci Rep       Date:  2015-07-10       Impact factor: 4.379

4.  The Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC) trial: Rationale and design of a multi-center, double-blind, placebo-controlled trial of high dose bolus administration of vitamin D3 during acute pulmonary exacerbation of cystic fibrosis.

Authors:  Vin Tangpricha; Ellen M Smith; Jose Binongo; Suzanne E Judd; Thomas R Ziegler; Seth Walker; Rabindra Tirouvanziam; Susu M Zughaier; Moon Jeong Lee; Supavit Chesdachai; Wendy A Hermes; James F Chmiel; Amit Gaggar; Ruth E Grossmann; Patricia M Joseph; Jessica A Alvarez
Journal:  Contemp Clin Trials Commun       Date:  2017-03-09

Review 5.  Update on the management of vitamins and minerals in cystic fibrosis.

Authors:  Senthilkumar Sankararaman; Sara J Hendrix; Terri Schindler
Journal:  Nutr Clin Pract       Date:  2022-08-23       Impact factor: 3.204

6.  Serum leptin and neuropeptide Y in patients with cystic fibrosis-A single center study.

Authors:  Sabina Galiniak; Rafał Podgórski; Marta Rachel; Artur Mazur
Journal:  Front Med (Lausanne)       Date:  2022-09-14

Review 7.  Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis.

Authors:  Adam J Causer; Janis K Shute; Michael H Cummings; Anthony I Shepherd; Mathieu Gruet; Joseph T Costello; Stephen Bailey; Martin Lindley; Clare Pearson; Gary Connett; Mark I Allenby; Mary P Carroll; Thomas Daniels; Zoe L Saynor
Journal:  Redox Biol       Date:  2020-01-23       Impact factor: 11.799

8.  Copper and Copper/Zinc Ratio in a Series of Cystic Fibrosis Patients.

Authors:  Marlene Fabiola Escobedo-Monge; Enrique Barrado; Carmen Alonso Vicente; María Antonieta Escobedo-Monge; María Carmen Torres-Hinojal; José Manuel Marugán-Miguelsanz; María Paz Redondo Del Río
Journal:  Nutrients       Date:  2020-10-30       Impact factor: 5.717

9.  Effect of Fat-Soluble Vitamins A, D, E and K on Vitamin Status and Metabolic Profile in Patients with Fat Malabsorption with and without Urolithiasis.

Authors:  Roswitha Siener; Ihsan Machaka; Birgit Alteheld; Norman Bitterlich; Christine Metzner
Journal:  Nutrients       Date:  2020-10-12       Impact factor: 5.717

10.  CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis.

Authors:  Olaf Sommerburg; Susanne Hämmerling; S Philipp Schneider; Jürgen Okun; Claus-Dieter Langhans; Patricia Leutz-Schmidt; Mark O Wielpütz; Werner Siems; Simon Y Gräber; Marcus A Mall; Mirjam Stahl
Journal:  Antioxidants (Basel)       Date:  2021-03-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.